CHELSEA COLLINS: Open Payments
NPI 1952837932 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,518 in 99 payments from 41 companies in 2025. Trend: 2023 $1,913 · 2024 $1,544 · 2025 $2,518
Food & beverage: $2,518
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $241 |
| AstraZeneca Pharmaceuticals LP | 9 | $219 |
| Janssen Biotech, Inc. | 8 | $208 |
| Celgene Corporation | 6 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| Daiichi Sankyo Inc. | 4 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $101 |
| Eisai Inc. | 3 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| Aveo Pharmaceuticals, Inc. | 2 | $66 |
Products named: LIBTAYO, KISQALI, Enhertu, Lenvima, BREYANZI, Nubeqa, CARVYKTI, ICLUSIG.
Industry payments across TN — which companies pay providers there.
